Get started
Author

Mallikarjuna Panchakshari

Observed institution: Biological E (India)
ORCID: 0000-0002-2060-1220
Observed ORCID: 0000-0002-2060-1220
OpenAlex ID: A5091591025
Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing
2021 · Jacob H. Gillis, Keely N. Thomas, et al. · Vaccine X · 8
PDF
Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5–80 years in India: a phase 3, single-blind, randomised controlled trial
2025 · Subhash Thuluva, Vikram Paradkar, et al. · The Lancet Regional Health - Southeast Asia · 4
Preclinical evaluation of a bivalent conjugate vaccine against Salmonella Typhi and Paratyphi A
2026 · Renzo Alfini, Roberta Di Benedetto, et al. · Frontiers in Immunology
PDF
Beyond immunogenicity in XBB.1.5 subunit COVID-19 boosters focusing on durability, dosing, and target populations: authors reply
2025 · Subhash Thuluva, Vikram Paradkar, et al. · The Lancet Regional Health - Southeast Asia
Works count: 4
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type